Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles
2-deoxy-2-[18F]fluoro-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) is indicated in head-and-neck cancer for the initial workup when clinically indicated (e. g., large tumors, clinically positive neck, cervical adenopathy from an unknown primary, etc.), for the assessme...
Main Authors: | Tim Van den Wyngaert, Stijn De Schepper, Laurens Carp |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01458/full |
Similar Items
-
Absolute Quantification in Diagnostic SPECT/CT: The Phantom Premise
by: Stijn De Schepper, et al.
Published: (2021-12-01) -
Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
by: Frank Hofheinz, et al.
Published: (2019-03-01) -
18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
by: Nils Helsen, et al.
Published: (2017-01-01) -
Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy
by: Frederik Soffers, et al.
Published: (2022-06-01) -
Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI
by: Christian Martin Meerwein, et al.
Published: (2015-02-01)